Anthropic has selected the Nasdaq as the venue for its planned initial public offering, a decision that puts the Claude maker on track for one of the largest AI listings to date. The selection was first reported by Business Insider and confirmed by Reuters. The move locks in a key logistical piece ahead of an eventual S-1 filing.
Choosing the Nasdaq puts Anthropic alongside the technology-heavy roster that includes Microsoft, Nvidia, and Meta, rather than the NYSE, which hosts Oracle and IBM. Exchange selection is typically one of the last major choices before a company begins the formal registration process. It signals that the underwriting, auditing, and governance work is far enough along to name a home for the ticker.
Anthropic has not publicly confirmed a filing date, and the company has declined to comment on IPO timing in past statements. Reuters reported the exchange selection based on the Business Insider account. Neither Anthropic nor the Nasdaq issued an on-the-record statement tied to the report.
Key facts
- 01Anthropic has selected Nasdaq over the New York Stock Exchange for its planned IPO.
- 02The decision was first reported by Business Insider and picked up by Reuters.
- 03An IPO would make Anthropic the first pure-play frontier AI lab to list publicly.
- 04The choice follows recent signals that Anthropic is preparing to file an S-1.
An Anthropic IPO would be the first true test of public-market appetite for a pure-play frontier AI lab. OpenAI remains privately held, and its CEO Sam Altman said last month that a 2026 listing would be ill-advised. That leaves Anthropic in position to set the template, and the comparables, for how Wall Street values a company whose revenue and compute costs are both climbing steeply.
The company's core product, Claude, competes directly with OpenAI's ChatGPT and Google's Gemini across coding, enterprise chat, and agentic workflows. Anthropic has leaned into the enterprise and API segments, with heavy adoption from developer tools and coding assistants. That mix tends to produce more predictable revenue than consumer chatbots, which matters when public investors start modeling the business.
The decision also arrives against a backdrop of intensifying debate inside Anthropic about the pace of AI development. CEO Dario Amodei has spent recent weeks urging rival labs to slow model development, and a former Anthropic researcher's warning about AI existential risk went viral earlier this month. Going public typically raises the bar for disclosure on exactly those questions, from safety incidents to risk factors around model misuse.
For the Nasdaq, landing Anthropic is a competitive win. The exchange has historically dominated large technology listings, but the NYSE has made a concerted push in recent years for AI-adjacent names. A frontier-lab IPO on the Nasdaq reinforces the exchange's status as the default home for the current AI cycle.
The remaining unknowns are the ones that matter most to investors: the target valuation, the size of the offering, the lead underwriters, and the timing. None of those have been disclosed. Anthropic's most recent private fundraising rounds have been reported at valuations that would place any IPO among the largest tech debuts on record, but a private mark and a public price are different things, and the gap between them tends to widen when macro conditions shift.
The exchange choice is a procedural milestone rather than a market-moving one, but it narrows the field of what happens next. Underwriter mandates, an S-1 draft, and a roadshow are the next visible steps. On current signals, the AI IPO cycle that public-market investors have been waiting for begins with Anthropic on the Nasdaq — and the pricing of that deal will set the anchor for every frontier-lab listing that follows.
Working on something we should cover, or seeing a story we missed? Send leads, documents, or feedback to hello@aichatdaily.com. For sensitive tips, see our secure tips page for Signal and PGP options.
Spotted an error? Email hello@aichatdaily.com with the URL and the issue, or read our full corrections policy.
